Company · CIK 0002123613 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Kardigan, Inc. · KARD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 PForm 4 → | Jun 24, 9:26 pm EDT | HRTG GPE, LLC +410% Owner | 3,125,000 | $16.00 | $50,000,000 | 14,866,868 | +26.6% | |
| Jun 22, 2026 PForm 4 → | Jun 24, 4:20 pm EDT | Paul L BernsDirector, 10% Owner | 1,250,000 | $16.00 | $20,000,000 | 15,042,035 | +9.06% | |
| Jun 22, 2026 PForm 4 → | Jun 24, 4:18 pm EDT | ARCH Venture Partners XIII, LLC +6Director, 10% Owner | 1,250,000 | $16.00 | $20,000,000 | 15,042,035 | +9.06% | |
| Jun 17, 2026 AForm 4 → | Jul 13, 4:44 pm EDT | PERCEPTIVE ADVISORS LLC +3Director | 20,706 | — | — | 20,706 | — | late |
| Jun 17, 2026 CForm 4 → | Jun 22, 9:57 pm EDT | HRTG GPE, LLC +410% Owner | 13,792,034 | — | — | 11,741,868 | — | |
| Jun 17, 2026 CForm 4 → | Jun 22, 7:39 pm EDT | ARCH Venture Partners XIII, LLC +6Director, 10% Owner | 13,792,035 | — | — | 13,792,035 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 7:30 pm EDT | Andy PasternakChief Strategy Officer | 79,640 | — | — | 79,640 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 7:28 pm EDT | David P MeekerDirector | 20,706 | — | — | 20,706 | — | |
| Jun 17, 2026 ACForm 4 → | Jun 22, 7:24 pm EDT | Paul L BernsDirector, 10% Owner | 13,812,741 | — | — | 20,706 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 7:23 pm EDT | John B MoriartyChief Legal Officer | 47,784 | — | — | 47,784 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 7:20 pm EDT | Brianne JahnChief Financial Officer | 79,640 | — | — | 79,640 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 7:19 pm EDT | Kimberly J PopovitsDirector | 20,706 | — | — | 20,706 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 7:17 pm EDT | Timothy P WalbertDirector | 20,706 | — | — | 20,706 | — | |
| Jun 17, 2026 CForm 4 → | Jun 22, 7:17 pm EDT | Anastasios GianakakosPresident & CEO, Director | 568,395 | — | — | 498,692 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 7:15 pm EDT | Douglas E. GiordanoDirector | 20,706 | — | — | 20,706 | — | |
| Jun 17, 2026 ACForm 4 → | Jun 22, 7:14 pm EDT | Jay EdelbergChief Medical Officer | 145,371 | — | — | 183,327 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 CForm 4 → | Jun 22, 9:57 pm EDT | HRTG GPE, LLC +410% Owner | 8,658,987 | — | — | 0 | — | |
| Jun 17, 2026 CForm 4 → | Jun 22, 7:39 pm EDT | ARCH Venture Partners XIII, LLC +6Director, 10% Owner | 8,658,988 | — | — | 0 | — | |
| Jun 17, 2026 CForm 4 → | Jun 22, 7:24 pm EDT | Paul L BernsDirector, 10% Owner | 8,658,988 | — | — | 0 | — | |
| Jun 17, 2026 AForm 4 → | Jun 22, 7:17 pm EDT | Timothy P WalbertDirector | 57,573 | — | — | 57,573 | — | |
| Jun 17, 2026 CForm 4 → | Jun 22, 7:17 pm EDT | Anastasios GianakakosPresident & CEO, Director | 356,854 | — | — | 0 | — | |
| Jun 17, 2026 CForm 4 → | Jun 22, 7:14 pm EDT | Jay EdelbergChief Medical Officer | 61,268 | — | — | 0 | — |